Central nervous system relapse in patients with primary mediastinal large b-cell lymphoma: incidence and risk factors in the Rituximab era

2024-11-0920220006-497110.1182/blood-2022-168627http://dx.doi.org/10.1182/blood-2022-168627https://hdl.handle.net/20.500.14288/7527N/AHematologyCentral nervous system relapse in patients with primary mediastinal large b-cell lymphoma: incidence and risk factors in the Rituximab eraMeeting Abstract1528-0020893230302244Q111961